Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice

Hiroyuki Mizoguchi1, Kiyofumi Yamada, Minae Niwa

  • 1Department of Neuropsychopharmacology and Hospital Pharmacy, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Insights

Matrix metalloproteinases (MMPs), specifically MMP-2 and MMP-9, are crucial for methamphetamine

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulate the extracellular matrix.
  • MMP activity is linked to synaptic plasticity and neurological disorders.

Purpose of the Study:

  • To investigate the role of MMP-2 and MMP-9 in the rewarding effects and sensitization to methamphetamine (METH).
  • To understand how MMPs influence neural circuit remodeling in response to METH.

Main Methods:

  • Utilized MMP-2 and MMP-9 deficient mice (MMP-2-/- and MMP-9-/-).
  • Assessed METH-induced behavioral sensitization and conditioned place preference.
  • Measured dopamine release and uptake in the nucleus accumbens (NAc) and striatal synaptosomes.

Main Results:

  • Repeated METH treatment increased MMP-2 and MMP-9 activity.
  • METH-induced sensitization, reward, and dopamine release were attenuated in MMP-deficient mice.
  • MMP-2 infusion potentiated METH-induced dopamine release.
  • METH reduced dopamine uptake, an effect blunted in MMP-deficient mice.

Conclusions:

  • MMP-2 and MMP-9 are critical mediators of METH's rewarding effects and behavioral sensitization.
  • These MMPs regulate dopamine release and uptake in the NAc, influencing METH's impact on neural circuits.

Related Concept Videos